SCHEMBL301204

SCHEMBL301204

Cc1nc(C(C)(C)C)sc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
HPGD P15428 1/20 0.55
TSHR P16473 1/20 0.55
CNR1 P21554 1/20 0.50
CNR2 P34972 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 5/20 0.46
RAB9A P51151 3/20 0.46
GAA P10253 1/20 0.46
NPC1 O15118 2/20 0.44
POLB P06746 1/20 0.44
PIK3CD O00329 1/20 0.42
PIK3CA P42336 1/20 0.42
PIK3CB P42338 1/20 0.42
KMT2A Q03164 1/20 0.41
PKM P14618 2/20 0.38
HSP90AA1 P07900 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
TARBP2 Q15633 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21985442 0.85 ALDH1A1 (0.52) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL14357152 0.84 CNR1 (0.50) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL9643792 0.82 ALDH1A1 (0.53) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL5519898 0.82 CNR1 (0.49) ALDH1A1HPGDTSHRCNR1CNR2
Hydrochloric Acid SCHEMBL9644334 0.81 ALDH1A1 (0.52) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL9642854 0.80 ALDH1A1 (0.41) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL5521979 0.80 ALDH1A1 (0.37) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL160229 0.79 CNR1 (0.50) ALDH1A1HPGDTSHRCNR1CNR2
SCHEMBL13401035 0.79 ALDH1A1 (0.48) ALDH1A1CNR1CNR2SMN1; SMN2KDM4E
SCHEMBL5528925 0.78 CNR1 (0.46) ALDH1A1HPGDTSHRCNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109096274-A It can be used for treating the aryl-linking compound of human tumor, neurology and amynologic disease 比奥根MA公司 2018-12-28 CN disclosed
CN-108947913-A It can be used for treating the aryl-linking compound of human tumor, neurology and amynologic disease 比奥根MA公司 2018-12-07 CN disclosed
CN-106459002-B Biaryl compounds useful in the treatment of human oncological, neurological and immunological diseases 比奥根MA公司 2018-08-21 CN disclosed
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2012-05-03 US disclosed
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2012-05-03 US disclosed
EP-2404908-A1 PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST Teijin Pharma Limited (JP) 2012-01-11 EP disclosed
US-5136042-A PROCESS FOR THE PREPARATION OF THIAZOLECARBOXYLIC ACID CHLORIDES MITSUI TOATSU CHEMICALS, INC. (JP) 1992-08-04 US disclosed
EP-0377750-A1 PROCESS FOR PREPARING THIAZOLECARBOXYLIC ACID CHLORIDES MITSUI CHEMICALS, INC. (JP) 1990-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108565-A1 PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS POLI, POLB, POLA1 ALDH1A1 2042/4885HPGD 563/4885TSHR 3395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.